http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28210949

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article|Multicenter Study
endingPage 1724
issn 0007-0920
1532-1827
issueIdentifier 11
pageRange 1720-1724
publicationName British Journal of Cancer
startingPage 1720
bibliographicCitation Vasile E, Masi G, Fornaro L, Cupini S, Loupakis F, Bursi S, Petrini I, Di Donato S, Brunetti IM, Ricci S, Antonuzzo A, Chiara S, Amoroso D, Andreuccetti M, Falcone A. A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer. British Journal of Cancer. 2009 May 12;100(11):1720–4. doi: 10.1038/sj.bjc.6605075.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51d8b608511f5c98af88ca77746c8d2b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5af48bbcf8809966ea53741cf1f8b054
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d79df6b0a3728c68011717bb8e22be84
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65258744cb7800069b1bae545b4757ad
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70385d1599efc87df1751524c83049d9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61afc0b60abb88a737820e6f4c4dbf6d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4bbcbb05ebb03a0d3f9bac60cac51afc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0211e4ec8b9f2074ee070701b0c7a11d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_876d89a9d72c556c570f1eedd36a7756
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa8bcc6dd3b9bb7a6bde43f6085515b2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_783c9b0b8a32d9a161b106a1f88027b5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc63de458d47709a79b17241373ecba3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d52a57cd407ce869731a5018514d9f67
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7c724d2324a93edebff84d47ae35362
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa649fb04164fcb82f58c09a7145636a
date 2009-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2695688
https://doi.org/10.1038/sj.bjc.6605075
https://pubmed.ncbi.nlm.nih.gov/19436300
isPartOf https://portal.issn.org/resource/ISSN/1532-1827
https://portal.issn.org/resource/ISSN/0007-0920
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
discusses http://id.nlm.nih.gov/mesh/M0095550
http://id.nlm.nih.gov/mesh/M0005997
http://id.nlm.nih.gov/mesh/M0147530
http://id.nlm.nih.gov/mesh/M0015422
http://id.nlm.nih.gov/mesh/M0003242
http://id.nlm.nih.gov/mesh/M0008631
http://id.nlm.nih.gov/mesh/M0287377
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9887053
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141643
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7507
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136170999

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129430288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127925204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129555111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129202881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129113875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129281950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129520161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127638306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129143706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127796650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129532320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136058681

Total number of triples: 72.